LRP1 and Alzheimer disease: Paricalcitol stimulated LRP-1 expression, increased the lysosomal degradation of BACE1 (β-site APP-cleaving enzyme 1) and attenuated calpain-1-mediated neuronal loss in this animal model of AD [117].